• Daihan Pharmaceutical Chairman Lee Yoon Woo bought 414 common shares through market purchases on Oct. 21-23, 2026.
• His holdings rose to 1,500,764 shares, with the reported ownership stake unchanged at 25.01%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Daihan Pharmaceutical Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261023000359), on October 23, 2026, and is solely responsible for the information contained therein.